“In vivo” visualization by positron emission tomography of the progressive striatal dopamine receptor damage occuring in MPTP-intoxicated non-human primates
- 1 October 1986
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 39 (15) , 1375-1382
- https://doi.org/10.1016/0024-3205(86)90336-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- NORMAL MPTP BINDING IN PARKINSONIAN SUBSTANTIA NIGRA: EVIDENCE FOR EXTRANEURONAL TOXIN CONVERSION IN HUMAN BRAINThe Lancet, 1985
- Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTPEuropean Journal of Pharmacology, 1984
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- 76Br-bromospiroperidol: A new tool for quantitative in-vivo imaging of neuroleptic receptorsLife Sciences, 1984
- High-affinity binding sites for [3H]MPTP may correspond to monamine oxidaseEuropean Journal of Pharmacology, 1984
- Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: Potential agents for imaging the dopamine receptorLife Sciences, 1983
- Imaging Dopamine Receptors in the Human Brain by Positron TomographyScience, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973